Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer	Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, transitional cell carcinoma, urothelial carcinoma	Recruiting	Phase 2	2026-07-16		NCT06356155

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Michigan Rogel Cancer Center	63

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Fox Chase Cancer Center	Philadelphia	United States	259
University of Michigan Comprehensive Cancer Center	Ann Arbor	United States	88

Clinical trials